AAAAAA
Results:
1-8
|
Results: 8
Authors:
Parish, LC
Routh, HB
Miskin, B
Fidelholtz, J
Werschler, P
Heyd, A
Haverstock, D
Church, D
Citation: Lc. Parish et al., Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections, INT J CL PR, 54(8), 2000, pp. 497-503
Authors:
Patel, T
Pearl, J
Williams, J
Haverstock, D
Church, D
Citation: T. Patel et al., Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia, RESP MED, 94(2), 2000, pp. 97-105
Authors:
Chodosh, S
DeAbate, CA
Haverstock, D
Aneiro, L
Church, D
Citation: S. Chodosh et al., Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis, RESP MED, 94(1), 2000, pp. 18-27
Authors:
Heyd, A
Haverstock, D
Citation: A. Heyd et D. Haverstock, Retrospective analysis of the safety profile of oral and intravenous ciprofloxacin in a geriatric population, CLIN THER, 22(10), 2000, pp. 1239-1250
Authors:
Segev, S
Yaniv, I
Haverstock, D
Reinhart, H
Citation: S. Segev et al., Safety of long-term therapy with ciprofloxacin: Data analysis of controlled clinical trials and review, CLIN INF D, 28(2), 1999, pp. 299-308
Authors:
Krumpe, PE
Cohn, S
Garreltes, J
Ramirez, J
Coulter, H
Haverstock, D
Echols, R
Citation: Pe. Krumpe et al., Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy, J ANTIMICRO, 43, 1999, pp. 117-128
Authors:
Kanga, J
Kuhn, R
Craigmyle, L
Haverstock, D
Church, D
Citation: J. Kanga et al., Cystic fibrosis clinical score: A new scoring system to evaluate acute pulmonary exacerbation, CLIN THER, 21(8), 1999, pp. 1343-1356
Authors:
Burke, T
Villanueva, C
Mariano, H
Huck, W
Orchard, D
Haverstock, D
Heyd, A
Church, D
Citation: T. Burke et al., Comparison of moxifloxacin and cefuroxime axetil in the treatment of acutemaxillary sinusitis, CLIN THER, 21(10), 1999, pp. 1664-1677
Risultati:
1-8
|